AbbVie | ABBV - Рыночная капитализация





Рыночная капитализация Изменить Дата
AbbVie USD 508.97B 46.71B 2026-11
Abbott USD 171.01B 12.96B 2026-09
ALKERMES USD 7.43B 629M 2026-11
Amgen USD 247.94B 20.06B 2026-11
AstraZeneca USD 213.88B 23.43B 2026-11
Biogen USD 33.38B 1.48B 2026-09
BioMarin Pharmaceutical USD 10.68B 936M 2026-11
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Coherus Biosciences USD 172M 19M 2025-12
Eisai JPY 1.2T 219.32B 2026-06
Eli Lilly USD 1.09T 40.33B 2026-09
Gilead Sciences USD 184.82B 27.96B 2026-09
GlaxoSmithKline GBP 74.11B 6.03B 2026-09
J&J USD 653.61B 42.25B 2026-09
Medtronic USD 109.3B 2.33B 2026-06
Merck USD 375.59B 17.09B 2026-11
Neurocrine Biosciences USD 16.38B 1.96B 2026-11
Novartis USD 292.09B 51.5B 2026-09
Pacira USD 1.69B 695M 2026-11
Perrigo USD 2.17B 31M 2026-11
Pfizer USD 165.12B 1.71B 2026-11
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 100.56B 13.53B 2026-11
UCB EUR 46.41B 13.94B 2025-12
Ultragenyx Pharmaceutical USD 1.37B 108M 2026-11
United Therapeutics USD 28.64B 5.4B 2026-11
Vertex Pharmaceuticals USD 140.44B 7.93B 2026-11
Zoetis USD 37.6B 8.74B 2026-11